Medical News

RSS

FDA clears RyMed's InVision-Plus CS needleless IV connector

RyMed Technologies announced today that it has received FDA 510(k) clearance for its newest IV connector, InVision-Plus® CS™ with Chlorhexidine-Silver Ion Engineering.

10 Aug 2010

Atrium awarded 3-year national contract from Premier for surgical mesh products

Atrium Medical Corporation, pioneering advancements in biological, mechanical and therapeutic solutions for soft tissue reinforcement, is proud to announce that the company was awarded a three-year national contract from Premier Purchasing Partners L.P., the group purchasing organization of Premier, Inc. (Charlotte, NC).

10 Aug 2010

CADTH Review Panel releases recommendations for Biologic Response Modifier Agents for Adults with RA

The Canadian Agency for Drugs and Technologies in Health's (CADTH) Therapeutic Review Panel released last week their recommendations for Biologic Response Modifier Agents for Adults with Rheumatoid Arthritis (RA).

10 Aug 2010

Study results provide rationale for use of PI3K inhibitors in therapeutic settings

Research at the Babraham Institute, investigating how white blood cells known as B cells develop, has revealed that genes from the Phosphatidylinositol 3-kinase family of enzymes are critical in enabling the B cells to produce antibodies in the spleen and lymph nodes.

10 Aug 2010

Vertex reports results from Phase 3 ILLUMINATE study of telaprevir-based therapy for hepatitis C

Vertex Pharmaceuticals Incorporated today announced results from the Phase 3 ILLUMINATE study, which was designed to evaluate whether there was any benefit to extending therapy from 24 to 48 weeks in people whose hepatitis C virus (HCV) was undetectable at weeks 4 and 12 of treatment (extended rapid viral response or eRVR).

10 Aug 2010

Arrowhead Research signs option agreement for new technology platform to kill fat tissue

Arrowhead Research Corporation today announced that it has signed an option agreement with The University of Texas MD Anderson Cancer Center to negotiate a license in a defined field to a class of compounds that is believed to kill fat tissue by specifically targeting the blood vessels that supply it. The technology was developed in the laboratory of Drs. Renata Pasqualini and Wadih Arap at MD Anderson in Houston, Texas.

10 Aug 2010

Quick-Med develops new NIMBUS Advanced Active prototype wound dressing

Quick-Med Technologies, Inc. announced today the development of a new prototype wound dressing, NIMBUS® Advanced Active, developed as part of ongoing research currently being funded by the U.S. Army Medical Research and Material Command under a $900,000 Small Business Innovation Research (SBIR) grant. NIMBUS was competitively selected by the U.S. Army for evaluation in the healing of vesicant injuries, and this new dressing is the first "active" wound healing product developed by Quick-Med.

10 Aug 2010

Water Pik sets up online community to support portfolio of oral health, shower head and sinus health products

In an effort to educate and inform consumers, Water Pik, Inc., a global leader in personal healthcare products, today announced the launch of its new online community on Waterpik.com. Powered by Lithium Technologies, the online destination supports Water Pik's entire portfolio of oral health, shower head and sinus health products and brings the company's experts, consumers and industry experts together in one digital space.

10 Aug 2010

Henry Schein announces new $400 million private placement shelf facilities

Henry Schein, Inc., the largest provider of health care products and services to office-based practitioners, today announced that it has entered into new $400 million private placement shelf facilities with two insurance companies.

10 Aug 2010

Inhibitex reports net loss of $5.6 million for second-quarter 2010

Inhibitex, Inc. today announced its financial results for the second quarter ended June 30, 2010.

10 Aug 2010

Graymark Healthcare second-quarter consolidated net revenues increase 12% to $28.3 million

Graymark Healthcare, Inc. today announced financial results for the quarter ending June 30, 2010 including $1.1MM of EBITDA on $28.3MM in sales.

10 Aug 2010

Analysis finds no evidence that inclusion of retinyl palmitate in sunscreens can cause cancer

Despite previous concerns about the cancer-causing potential of sunscreens containing retinyl palmitate (vitamin A), an independent analysis published online in the Journal of the American Academy of Dermatology determined that there is no evidence that the inclusion of retinyl palmitate in sunscreens can cause cancer in humans.

10 Aug 2010

Teleflex announces closing of $400 million 3.875% Convertible Senior Subordinated Notes offering

Teleflex Incorporated today announced it closed its $400 million offering of its 3.875% Convertible Senior Subordinated Notes due 2017, which amount includes $50 million in connection with the exercise in full by the underwriters of their option to purchase additional notes. Goldman, Sachs & Co., Jefferies & Company, Inc., Morgan Stanley & Co. Incorporated, BofA Merrill Lynch and J.P. Morgan Securities Inc. acted as underwriters.

10 Aug 2010

General Nutrition Centers second-quarter net income increases 42.5% to $25.6 million

General Nutrition Centers, Inc., a leading global specialty retailer of nutritional products, today reported its financial results for the quarter ended June 30, 2010.

10 Aug 2010

Language Line University offers new scalable online training tool for medical interpreters

Language Line(R) University, the interpreter assessment and training division of Language Line Services, an over-the-phone and video interpretation services provider, is offering a new scalable online training tool for medical interpreters. LLU Web Advanced Medical Training for Interpreters, the first of its kind in the industry, combines 15 hours of self-paced Web activities with 10 hours of live over-the-phone instructor-led sessions. Completion of the course qualifies participants to receive 10 continuing education points from the American Translators Association.

10 Aug 2010

WebMD commences common stock repurchase program

WebMD Health Corp. announced today that it has commenced a tender offer to purchase up to 3,000,000 shares of its common stock at a price of $52.00 per share. The price per share of $52.00 represents a change from the price per share of $50.00 that WebMD previously announced on August 5, 2010.

10 Aug 2010

Response Biomedical second-quarter revenue from product sales increases 2%

Response Biomedical Corporation today announced financial results for the second quarter and six months ended June 30, 2010.

10 Aug 2010

Theragenics reports consolidated revenue of $20.8M for second-quarter 2010

Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced consolidated financial results for the second quarter ended June 30, 2010.

10 Aug 2010

NeuroMetrix second-quarter total revenues decrease to $3.9 million

NeuroMetrix, Inc., a health care company transforming patient care through neurotechnology, today announced its financial results for the quarter ended June 30, 2010.

10 Aug 2010

Vanguard Management, Go Healthy announce consulting, management and distribution agreement

Vanguard Management Corp (a business unit of Vanguard Minerals Corp) announced that the company has signed a comprehensive consulting, management and distribution agreement with Go Healthy, Inc, a marketer of innovative nutrition products, namely Cholesterade.

10 Aug 2010

Medical News

FDA clears RyMed's InVision-Plus CS needleless IV connector

Atrium awarded 3-year national contract from Premier for surgical mesh products

CADTH Review Panel releases recommendations for Biologic Response Modifier Agents for Adults with RA

Study results provide rationale for use of PI3K inhibitors in therapeutic settings

Vertex reports results from Phase 3 ILLUMINATE study of telaprevir-based therapy for hepatitis C

Arrowhead Research signs option agreement for new technology platform to kill fat tissue

Quick-Med develops new NIMBUS Advanced Active prototype wound dressing

Water Pik sets up online community to support portfolio of oral health, shower head and sinus health products

Henry Schein announces new $400 million private placement shelf facilities

Inhibitex reports net loss of $5.6 million for second-quarter 2010

Graymark Healthcare second-quarter consolidated net revenues increase 12% to $28.3 million

Analysis finds no evidence that inclusion of retinyl palmitate in sunscreens can cause cancer

Teleflex announces closing of $400 million 3.875% Convertible Senior Subordinated Notes offering

General Nutrition Centers second-quarter net income increases 42.5% to $25.6 million

Language Line University offers new scalable online training tool for medical interpreters

WebMD commences common stock repurchase program

Response Biomedical second-quarter revenue from product sales increases 2%

Theragenics reports consolidated revenue of $20.8M for second-quarter 2010

NeuroMetrix second-quarter total revenues decrease to $3.9 million

Vanguard Management, Go Healthy announce consulting, management and distribution agreement

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Latest News